Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Volume-stable collagen matrix vs. connective tissue graft for peri-implant soft-tissue defects

Official title: Clinical, Histological, Biomolecular, and Ultrasonographic Analysis of the Efficacy of a Volume-Stable Collagen Matrix Versus an Autogenous Connective Tissue Graft in the Treatment of Peri-Implant Soft-Tissue Defects

Run by Ankara University · NCT07782125 · Data updated 2026-11-12

This trial tests whether a volume-stable collagen matrix can match the standard connective tissue graft for improving soft tissue around a dental implant in adults with a single missing tooth.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment22 (estimated)
SponsorAnkara University
Academic / other
Locations1 site (Ankara, Yeni̇mahalle)
StatusRecruiting
StartedDecember 18, 2025
Main results expectedSeptember 1, 2026
Study endsSeptember 1, 2026
Registry record updatedAugust 24, 2026
Trial IDNCT07782125 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults over 18 needing a single-tooth anterior implant with a requirement for peri-implant soft-tissue augmentation and good general and oral health.

Probably not a fit

Patients with conditions that impair healing, active periodontal disease or peri-implantitis, or those who smoke or recently quit may see little to no benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center, randomized trial compares a volume-stable collagen matrix (VCMX) to autogenous connective tissue graft (CTG) for augmenting peri-implant soft tissue after single-tooth implant placement. Participants undergo standardized surgical procedures with evaluation of soft-tissue thickness, echo intensity, and blood flow using high-resolution intraoral ultrasound and Power Doppler, alongside clinical periodontal measures and patient-reported outcomes over six months. Histological and immunohistochemical analyses are planned from gingival biopsy samples at healing abutment placement to complement noninvasive assessments. The study aims to determine whether VCMX can provide similar esthetic and healing outcomes to CTG while avoiding a donor-site morbidity. Primary outcomes focus on changes in soft-tissue characteristics and healing at multiple time points.

Why it matters

Potential benefit: If successful, the collagen matrix could offer an effective, donor-site–free option for soft-tissue augmentation around implants.

How similar studies have gone: Prior research suggests CTG remains effective, and while collagen matrices show promise, robust comparative data with multidimensional assessment are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age \>18 years
* Periodontal health confirmed according to the 2017 World Workshop criteria (BOP \<10%, PD ≤3 mm, absence of gingival inflammation, and good oral hygiene) (Tonetti et al., 2018)
* Requirement of implant placement and soft-tissue augmentation for a single missing tooth in the anterior region
* Bleeding on probing \<30% at the adjacent teeth (Thoma et al., 2016)
* Compliance with the study protocol and follow-up visits

Exclusion Criteria:

* Siebert Class II or Class III defects
* History of surgery at the treated site
* Untreated periodontitis or peri-implantitis
* Current smoking or smoking within the previous five years
* Systemic conditions (that may impair healing)
* Pregnancy or lactation
* Allergy to the materials/drugs used
* Drug use affecting mucosal healing
* History of antibiotic therapy within the previous six months

Where it's running

  • Faculty of Dentistry, Ankara University
    Ankara, Yeni̇mahalle, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.